Dynavax Technologies Corp financial data

Symbol
DVAX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 Powell Street, Suite 720, Emeryville, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.31K % +0.05%
Quick Ratio 96.2 % +13.9%
Debt-to-equity 59.5 % -6.56%
Return On Equity 4.3 %
Return On Assets 2.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares -5.21%
Common Stock, Shares, Outstanding 125M shares -3.15%
Entity Public Float 800M USD -11.1%
Common Stock, Value, Issued 125K USD -3.85%
Weighted Average Number of Shares Outstanding, Basic 130M shares +1.02%
Weighted Average Number of Shares Outstanding, Diluted 133M shares +3.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 277M USD +19.4%
Research and Development Expense 61.6M USD +12.1%
Costs and Expenses 281M USD +4.48%
Operating Income (Loss) -4.12M USD +88.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 30.9M USD +666%
Income Tax Expense (Benefit) 3.55M USD +75.4%
Net Income (Loss) Attributable to Parent 27.3M USD +3119%
Earnings Per Share, Basic 0.21 USD/shares
Earnings Per Share, Diluted 0.2 USD/shares +600%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.9M USD -36.2%
Inventory, Net 70.1M USD +31.5%
Assets, Current 849M USD -1.19%
Property, Plant and Equipment, Net 39M USD +4.57%
Operating Lease, Right-of-Use Asset 21.6M USD -11%
Goodwill 1.95M USD -5.85%
Other Assets, Noncurrent 74.8M USD +0.59%
Assets 986M USD -1.09%
Accounts Payable, Current 9.06M USD +72.8%
Accrued Liabilities, Current 61.1M USD +23.5%
Liabilities, Current 78.6M USD +26.4%
Operating Lease, Liability, Noncurrent 26.4M USD -11.2%
Other Liabilities, Noncurrent 244K USD +230%
Liabilities 389M USD +3.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.72M USD -124%
Retained Earnings (Accumulated Deficit) -903M USD +2.94%
Stockholders' Equity Attributable to Parent 597M USD -4.06%
Liabilities and Equity 986M USD -1.09%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.7M USD -160%
Net Cash Provided by (Used in) Financing Activities -4.2M USD -36%
Net Cash Provided by (Used in) Investing Activities 2.83M USD
Common Stock, Shares Authorized 278M shares 0%
Common Stock, Shares, Issued 125M shares -3.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.3M USD +34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 96.2M USD -36.1%
Deferred Tax Assets, Valuation Allowance 173M USD -4.36%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.24 pure +677%
Deferred Tax Assets, Gross 179M USD -5.33%
Operating Lease, Liability 30.6M USD -10.7%
Payments to Acquire Property, Plant, and Equipment 749K USD -41.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 24.7M USD -55.4%
Lessee, Operating Lease, Liability, to be Paid 41.3M USD -14%
Property, Plant and Equipment, Gross 73.2M USD +5.84%
Operating Lease, Liability, Current 4.18M USD -7.14%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.51M USD -6.68%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.94M USD -8.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.7M USD -22.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.46M USD +5.49%
Deferred Tax Assets, Operating Loss Carryforwards 77.8M USD -19.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 12.4M USD +2.47%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.44M USD +6.46%
Operating Lease, Payments 1.9M USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.82M USD -24.6%
Share-based Payment Arrangement, Expense 0 USD -100%
Interest Expense 6.78M USD +0.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%